NTLA vs BEAM
NTLA 与 BEAM 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | NTLAINTELLIA THERAPEUTICS, INC. | BEAMBeam Therapeutics Inc. |
|---|---|---|
| 市值 | $1.65B | $2.69B |
| 市净率 | — | 2.52 |
| 市销率 | 24.9x | 19.7x |
| 营收 | — | $156.03M(TTM) |
| 营收同比增长 | 16.9% | 120.0% |
| 净利润 | — | -$86.52M(TTM) |
| 净利同比增长 | 20.5% | 78.8% |
| 每股收益(稀释) | — | $-0.69(TTM) |
| 息税前利润率 | -651.7% | -274.6% |
| 净资产收益率 | -56.7% | -7.5% |
| 投入资本回报率 | — | -40.5% |
| 一年总回报 | -4.7% | +6.3% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:NTLA vs BEAM
| 指标 | NTLA | BEAM |
|---|---|---|
| 期末价值 | $8.3K | $13.8K |
| 总回报 | -16.9% | +38.4% |
| 年化收益 (CAGR) | -2.7% | +4.9% |
| 波动率 | 82.9% | 79.6% |
| 夏普比率 | 0.33 | 0.40 |
| 索提诺比率 | 0.50 | 0.62 |
| 最大回撤 | -96.5% | -89.1% |
基于 1694 个共同交易日,2020-02-06 → 2026-11-02 · 无风险利率 4.16%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)